[1] MAN R A，MARCELLIN P，HABAL F，et al. A randomized，placebo- controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen positive hepatitis B[J] .Hepatology，2000，32(2)：413-417. [2] LAU G K，TSIANG M，HOU J L，et al. Combination therapy with lamivudine and famciclovir for chronic hepatitis B infected Chinese patients：A viral dynamics study[J] .Hepatology，2000，32(2)：394-399. [3] MARGUES K R， LAU D T，MCKENZIE R，et al. Combination Therapy with famciclovir and Inter feron-α for the Treatment of chronic Hepatitis B[J] ．Infect Des，1998，178(11)：1483-1486. [4] LOK A S，LAI C L，LEUNG N，et al. Long term safety of lam ivudine treatment in patients with chronic hepatitis B[J] . Gastroenterology，2003，125(6)：1714-1722. [5] LOCARNINI S，SHAW T，SOZZI T，et al.．HBV mutants associated with clinical resistance to adefovir dipivoxil display only small decreases in antiviral sensitivity in vitro[J] . Hepatology，2004，40(Supp1 4)：244A. [6] YAO G B，ZHANG D R，WANG B E，et al. A study of the dosage and eficacy of entecavir for treating hepatitis B viru[J] . Chin J Hepatol(中华肝脏病杂志)，2005，13(7)：484-487. [7] GRAHAM C W．Treatment with interferons (Including pegylated interferens) in hepatitis B [J] .Semin Liver Dis，2004，24[Suppl 1] ：77-82． [8] WANG J，WANG Y，JIANG S Q. Negative Effect of IFN-α2b on HBV-DNA and CD25 in the Patients with Chronic Hepatitis B[J] . Chin Pharm J(中国药学杂志)，2008，43(1)：71-74.